Skip to content
Disclosery

EXANE DERIVATIVES: ECHO position timeline

Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of EXANE DERIVATIVES on ECHO, newest first. How the timeline and the estimate are built.

EXANE DERIVATIVES held 4 ECHO shares at 2022-06-30 per its 13F-HR filed 2022-07-12.

the latest 13F is the newest step

  1. period ended2022-06-30
    13F 4 shares
    Change vs previous 13F 0 shares

    <0.01% of the 13F portfolio, value $77.

    13F-HR 0001623883-22-000006 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  2. period ended2022-03-31
    13F 4 shares
    Change vs previous 13F -23,300 shares

    <0.01% of the 13F portfolio, value $97.

    13F-HR 0001623883-22-000004 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  3. period ended2021-12-31
    13F 23,304 shares
    Change vs previous 13F +23,192 shares

    0.15% of the 13F portfolio, value $614,038.

    13F-HR 0001623883-22-000002 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  4. period ended2021-09-30
    13F 112 shares
    Change vs previous 13F -33,950 shares

    <0.01% of the 13F portfolio, value $2,857.

    13F-HR 0001623883-21-000008 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  5. period ended2021-06-30
    13F 34,062 shares
    Change vs previous 13F +33,950 shares

    0.19% of the 13F portfolio, value $797,033.

    13F-HR 0001623883-21-000006 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  6. period ended2021-03-31
    13F 112 shares
    Change vs previous 13F 0 shares

    <0.01% of the 13F portfolio, value $2,688.

    13F-HR 0001623883-21-000004 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  7. period ended2020-12-31
    13F 112 shares
    Change vs previous 13F -1,382 shares

    <0.01% of the 13F portfolio, value $2,373.

    13F-HR 0001623883-21-000002 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  8. period ended2020-09-30
    13F/A 1,494 shares
    Change vs previous 13F not available

    0.01% of the 13F portfolio, value $37,184.

    13F-HR/A 0001623883-20-000010 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).